🔎 Trials Near Me

Akèy › Kansè tèt ak kou › Kalifòni

Etid klinik pou Kansè tèt ak kou nan Kalifòni

31 etid pou Kansè tèt ak kou ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site #0107, La Jolla
  • Site #0106, Los Angeles
  • Site#0144, Sacramento
  • ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06788990

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • ak 10 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • City of Hope National Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • ak 3 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07090499

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 9, La Jolla
  • ALX Center 11, Santa Monica
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

Intratumoral N17350 in Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
  • UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
  • ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07339176

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

  • Stanford University, Stanford
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06736379

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  • City of Hope, Duarte
  • Hoag Memorial Hospital Presbyterian, Irvine
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07020117

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06633224

Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

  • UC Davis Health, Sacramento
  • UC Davis Medical Center, Sacramento
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06722508

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

  • Site 105 - START Los Angeles, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07462377

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Glendale
  • California Research Institute, Los Angeles
  • ak 3 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

  • University of California, Davis, Sacramento
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06103669

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Ellison Clinic at Saint John's, Los Angeles
  • UCSF Medical Center at Mission Bay, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

  • Stanford University School of Medicine, Stanford
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT00568490

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06993844

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • St Joseph Heritage Healthcare, Santa Rosa
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Solvang
  • GSK Investigational Site, Stockton
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 3, 2026 · NCT07447050

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

  • Stanford University School of Medicine, Stanford
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 24, 2025 · NCT00230308

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 12, 2025 · NCT06606028

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Providence Medical Foundation (site 209), Santa Rosa
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Dec 11, 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Cedars Sinai Medical Center, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT05941507

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

  • City Of Hope, Duarte
  • Stanford Cancer Center, Palo Alto
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 15, 2025 · NCT05406167

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Moores Cancer Center UC San Diego Health, La Jolla
  • Keck School of Medicine of USC, Los Angeles
  • UCLA, Los Angeles
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

A Multicenter Cancer Biospecimen Collection Study

  • Curebase, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2025 · NCT04510129

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.